Rodberg James 4

What Happened

• James Rodberg, Chief Financial Officer of Sight Sciences (SGHT), was granted 86,940 restricted stock units (RSUs) on February 3, 2026. The grant is shown at $0.00 per share in the Form 4 because it is an award, not an open‑market purchase; the grant value was $562,500 (the RSU count equals $562,500 divided by the closing price on Feb 3, 2026).
• These RSUs are a compensation award (transaction code A) and do not represent immediate shares — each RSU is a contingent right to receive one share of common stock upon vesting.

Key Details

• Transaction date: February 3, 2026; reported on Form 4 filed February 5, 2026 (timely filing).
• Grant size: 86,940 RSUs; grant value reported as $562,500 (RSU count derived from closing price on grant date).
• Vesting: 16 equal quarterly installments starting March 31, 2026 and ending December 31, 2029, subject to continued service.
• Shares/ownership after grant (beneficially reported): 39,451 shares of common stock owned outright and 198,719 shares underlying unvested RSUs — total reported beneficial interest = 238,170 shares (includes unvested RSUs).
• Footnotes: F1 explains the RSU mechanics and vesting schedule; F2 breaks down the reported owned shares and unvested RSUs.

Context

• RSU grants are common executive compensation and do not reflect an immediate market buy or sell. Because these units vest over time, they signal future potential share issuances rather than an immediate change in the trading float.
• No indication of a 10b5-1 plan, tax withholding sale, or late filing in this report; the filing appears timely under Form 4 rules.